<DOC>
	<DOCNO>NCT00859313</DOCNO>
	<brief_summary>This study perform evaluate functionality device ( Sufentanil NanoTab® PCA System ) develop use patient self-administer ARX-F01 pain medication ( Sufentanil NanoTab 15 mcg ) treatment post-operative pain undergoing knee replacement surgery . Another goal study assess safety effectiveness non-invasive , sublingual route administration ARX-F01 decrease amount pain patient experience follow knee replacement surgery .</brief_summary>
	<brief_title>An Open-Label Functionality , Safety Efficacy Study Patients Undergoing Elective Unilateral Knee Replacement</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Sufentanil</mesh_term>
	<criteria>1 . Male female patient 45 80 year age . 2 . Patient schedule elective unilateral , unicondylar , bi tricompartmental , cement uncemented knee replacement general spinal anesthesia include use intrathecal opioid . 3 . Patient must classify American Society Anesthesiologists ( ASA ) class I III . 4 . Patient must Body Mass Index ( BMI ) 18 39 , inclusively . 5 . Female patient childbearing potential must use effective method birth control screen visit end study . Acceptable method birth control include oral transdermal contraceptive , condom , spermicidal foam , intrauterine device ( IUD ) , progestin implant injection , abstinence , vaginal ring , sterilization partner . The reason nonchildbearing potential , bilateral tubal ligation , bilateral oophorectomy , hysterectomy , postmenopausal ≥1 year , must specify patient 's CRF . 6 . The patient must willing able understand study procedure use pain scale , communicate meaningfully study personnel . 7 . The patient must manual dexterity handle Sufentnail NanoTab PCA System able follow direction use . 8 . The patient must provide write informed consent sign Informed Consent approve Institutional Review Board ( IRB ) . 1 . Patient previously undergone knee replacement knee . 2 . A passive rangeofmotion ( PRM ) use 12hour study period complete . 3 . Patient previously respond opioid analgesic treatment pain . 4 . Patient currently take take opioid 30 consecutive day daily use daily dose equivalent great 15 mg morphine within past three month prior surgery ( e.g . 3 dos per day Vicodin® , Norco® , Lortab® 5 mg hydrocodone per tablet ) . 5 . Patient allergy hypersensitivity opioids . 6 . Patient take monoamine oxidase inhibitor ( MAOIs ) , take MAOIs within 14 day prior enrol study . 7 . Patient currently sleep apnea document sleep laboratory study . 8 . Patient screen laboratory test value outside laboratory normal range consider clinically significant Investigator . 9 . Patient woman pregnant lactating . 10 . Patient psychiatric disease encephalopathy severe enough prevent patient provide reliable study documentation . 11 . Patient , Investigator 's judgment , adequate ability read understand English . 12 . Patient medical condition , Investigator 's opinion , could adversely impact patient 's participation safety , conduct study , interfere pain assessment , include fracture active infection . 13 . Patient clinically significant renal liver impairment could affect metabolism clearance sufentanil . 14 . Patient painful physical condition knee arthritis , opinion Investigator , may confound postoperative pain assessment . 15 . Patient history drug , prescription medicine , alcohol abuse within past 2 year positive drug screen test cocaine , amphetamine , barbiturate , phencyclidine , methadone screening . 16 . Patient receive oxygen therapy time screen . 17 . Patient participate clinical trial investigational drug device within 30 day screen visit schedule receive investigational product Sufentanil NanoTab PCA System participate study . Exclusion Criteria Prior Treatment Initiation : 1 . Patient respiratory rate le 8 breath per minute great 24 breath per minute . 2 . Patient arterial oxygen saturation pulse oximetry ( SpO2 ) less 90 % supplemental oxygen . 3 . Patient able answer question follow command . 4 . Patient vomit responsive standard treatment . 5 . The surgical procedure incision closure last 3 hour . 6 . There deviation surgical anesthetic protocol specify Section 6.1.2.1 .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>